All Stories

DNA sequencing shares slide amid 'headwinds' from Trump's NIH funding cuts

In Monday’s trading, Pacific Biosciences and 10x Genomics each saw their stock prices dive by 13% to 14%, while Illumina has been recovering from being caught up in the tariff battle between the U.S. and China.

Feb 10, 2025 - 22:48
 0
DNA sequencing shares slide amid 'headwinds' from Trump's NIH funding cuts
In Monday’s trading, Pacific Biosciences and 10x Genomics each saw their stock prices dive by 13% to 14%, while Illumina has been recovering from being caught up in the tariff battle between the U.S. and China.
Read More

Tags:

Previous Article

43rd Annual JP Morgan Healthcare Conference 2025

Next Article

Georgia system opens $566M tower

Related Posts

'Not a cost-cutting exercise': Novo Nordisk CSO explains rationale behind pharma's R&D shake-up

'Not a cost-cutting exercise': Novo Nordisk CSO explain...

Mar 20, 2025  0

Deerfield sues to stop Alcon’s 'unrelenting campaign' to take over Aurion

Deerfield sues to stop Alcon’s 'unrelenting campaign' t...

Feb 24, 2025  0

Procedural ‘loophole’ leaves NIH grants frozen, despite orders from federal judge: reports

Procedural ‘loophole’ leaves NIH grants frozen, despite...

Feb 21, 2025  0